Cargando…
Genome-wide screen for modifiers of Parkinson's disease genes in Drosophila
BACKGROUND: Mutations in parkin and PTEN-induced kinase 1 (Pink1) lead to autosomal recessive forms of Parkinson's disease (PD). parkin and Pink1 encode a ubiquitin-protein ligase and a mitochondrially localized serine/threonine kinase, respectively. Recent studies have implicated Parkin and Pi...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3094290/ https://www.ncbi.nlm.nih.gov/pubmed/21504582 http://dx.doi.org/10.1186/1756-6606-4-17 |
_version_ | 1782203536040263680 |
---|---|
author | Fernandes, Caroline Rao, Yong |
author_facet | Fernandes, Caroline Rao, Yong |
author_sort | Fernandes, Caroline |
collection | PubMed |
description | BACKGROUND: Mutations in parkin and PTEN-induced kinase 1 (Pink1) lead to autosomal recessive forms of Parkinson's disease (PD). parkin and Pink1 encode a ubiquitin-protein ligase and a mitochondrially localized serine/threonine kinase, respectively. Recent studies have implicated Parkin and Pink1 in a common and evolutionarily conserved pathway for protecting mitochondrial integrity. RESULTS: To systematically identify novel components of the PD pathways, we generated a genetic background that allowed us to perform a genome-wide F1 screen for modifiers of Drosophila parkin (park) and Pink1 mutant phenotype. From screening ~80% of the fly genome, we identified a number of cytological regions that interact with park and/or Pink1. Among them, four cytological regions were selected for identifying corresponding PD-interacting genes. By analyzing smaller deficiency chromosomes, available transgenic RNAi lines, and P-element insertions, we identified five PD-interacting genes. Among them, opa1 and drp1 have been previously implicated in the PD pathways, whereas debra (dbr), Pi3K21B and β4GalNAcTA are novel PD-interacting genes. CONCLUSIONS: We took an unbiased genetic approach to systematically isolate modifiers of PD genes in Drosophila. Further study of novel PD-interacting genes will shed new light on the function of PD genes and help in the development of new therapeutic strategies for treating Parkinson's disease. |
format | Text |
id | pubmed-3094290 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-30942902011-05-14 Genome-wide screen for modifiers of Parkinson's disease genes in Drosophila Fernandes, Caroline Rao, Yong Mol Brain Research BACKGROUND: Mutations in parkin and PTEN-induced kinase 1 (Pink1) lead to autosomal recessive forms of Parkinson's disease (PD). parkin and Pink1 encode a ubiquitin-protein ligase and a mitochondrially localized serine/threonine kinase, respectively. Recent studies have implicated Parkin and Pink1 in a common and evolutionarily conserved pathway for protecting mitochondrial integrity. RESULTS: To systematically identify novel components of the PD pathways, we generated a genetic background that allowed us to perform a genome-wide F1 screen for modifiers of Drosophila parkin (park) and Pink1 mutant phenotype. From screening ~80% of the fly genome, we identified a number of cytological regions that interact with park and/or Pink1. Among them, four cytological regions were selected for identifying corresponding PD-interacting genes. By analyzing smaller deficiency chromosomes, available transgenic RNAi lines, and P-element insertions, we identified five PD-interacting genes. Among them, opa1 and drp1 have been previously implicated in the PD pathways, whereas debra (dbr), Pi3K21B and β4GalNAcTA are novel PD-interacting genes. CONCLUSIONS: We took an unbiased genetic approach to systematically isolate modifiers of PD genes in Drosophila. Further study of novel PD-interacting genes will shed new light on the function of PD genes and help in the development of new therapeutic strategies for treating Parkinson's disease. BioMed Central 2011-04-19 /pmc/articles/PMC3094290/ /pubmed/21504582 http://dx.doi.org/10.1186/1756-6606-4-17 Text en Copyright ©2011 Fernandes and Rao; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Fernandes, Caroline Rao, Yong Genome-wide screen for modifiers of Parkinson's disease genes in Drosophila |
title | Genome-wide screen for modifiers of Parkinson's disease genes in Drosophila |
title_full | Genome-wide screen for modifiers of Parkinson's disease genes in Drosophila |
title_fullStr | Genome-wide screen for modifiers of Parkinson's disease genes in Drosophila |
title_full_unstemmed | Genome-wide screen for modifiers of Parkinson's disease genes in Drosophila |
title_short | Genome-wide screen for modifiers of Parkinson's disease genes in Drosophila |
title_sort | genome-wide screen for modifiers of parkinson's disease genes in drosophila |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3094290/ https://www.ncbi.nlm.nih.gov/pubmed/21504582 http://dx.doi.org/10.1186/1756-6606-4-17 |
work_keys_str_mv | AT fernandescaroline genomewidescreenformodifiersofparkinsonsdiseasegenesindrosophila AT raoyong genomewidescreenformodifiersofparkinsonsdiseasegenesindrosophila |